Barrière bets on vitamin patches to disrupt the supplement aisle
Barrière is expanding its line of transdermal vitamin patches into Walmart (1,700 stores) and other major retailers, aiming to reach $10 million in revenue in 2026. The patches target sleep, energy, immune support, digestion, and more, with products like a lactose-intolerance patch and a motion-sickness patch; they’re manufactured in the U.K. and deliver ingredients through the skin for up to 12 hours. The company touts convenience and marketing as key drivers in a $60 billion, highly crowded supplement market with limited FDA oversight.
